Incident pulmonary arterial hypertension associated with Bosutinib

Pulmonary arterial hypertension is associated with tyrosine kinase inhibitors used in the treatment of chronic myeloid leukemia. Dasatinib is a known cause of drug-induced pulmonary arterial hypertension. There have been case reports linking Bosutinib with deterioration of pre-existing pulmonary art...

Descripción completa

Detalles Bibliográficos
Autores principales: Yo, Shaun, Thenganatt, John, Lipton, Jeffrey, Granton, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443988/
https://www.ncbi.nlm.nih.gov/pubmed/32913629
http://dx.doi.org/10.1177/2045894020936913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443988/
https://www.ncbi.nlm.nih.gov/pubmed/32913629
http://dx.doi.org/10.1177/2045894020936913

Ejemplares similares